1. Home
  2. PBM vs VRAX Comparison

PBM vs VRAX Comparison

Compare PBM & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • VRAX
  • Stock Information
  • Founded
  • PBM 1994
  • VRAX 2013
  • Country
  • PBM Canada
  • VRAX United Kingdom
  • Employees
  • PBM N/A
  • VRAX N/A
  • Industry
  • PBM
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • PBM
  • VRAX Health Care
  • Exchange
  • PBM NYSE
  • VRAX Nasdaq
  • Market Cap
  • PBM 5.3M
  • VRAX 7.3M
  • IPO Year
  • PBM N/A
  • VRAX 2022
  • Fundamental
  • Price
  • PBM $1.40
  • VRAX $1.90
  • Analyst Decision
  • PBM
  • VRAX
  • Analyst Count
  • PBM 0
  • VRAX 0
  • Target Price
  • PBM N/A
  • VRAX N/A
  • AVG Volume (30 Days)
  • PBM 393.7K
  • VRAX 293.5K
  • Earning Date
  • PBM 02-02-2025
  • VRAX 02-05-2025
  • Dividend Yield
  • PBM N/A
  • VRAX N/A
  • EPS Growth
  • PBM N/A
  • VRAX N/A
  • EPS
  • PBM N/A
  • VRAX N/A
  • Revenue
  • PBM N/A
  • VRAX $84,872.00
  • Revenue This Year
  • PBM N/A
  • VRAX $5,169.18
  • Revenue Next Year
  • PBM N/A
  • VRAX $66.97
  • P/E Ratio
  • PBM N/A
  • VRAX N/A
  • Revenue Growth
  • PBM N/A
  • VRAX 7.03
  • 52 Week Low
  • PBM $1.15
  • VRAX $0.60
  • 52 Week High
  • PBM $323.25
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • PBM 41.45
  • VRAX 49.13
  • Support Level
  • PBM $1.15
  • VRAX $1.58
  • Resistance Level
  • PBM $1.59
  • VRAX $2.10
  • Average True Range (ATR)
  • PBM 0.20
  • VRAX 0.25
  • MACD
  • PBM 0.03
  • VRAX 0.01
  • Stochastic Oscillator
  • PBM 27.53
  • VRAX 47.88

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: